Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics
2021 · Nature Medicine · 363 citations
https://doi.org/10.1038/s41591-020-01227-z
C
Christoph H. Mayr
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
3.8K
Citations
20
h-index
26
i10-index
Christoph H. Mayr is an academic researcher from Boehringer Ingelheim (Germany). The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Neonatal Respiratory Health Research & Extracellular vesicles in disease. The author has an h-index of 20, co-authored 88 publications.
ORCID: 0000-0001-5353-4768Papers by this author
worksSfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts
2024 · European Respiratory Journal · 89 citations
https://doi.org/10.1183/13993003.01326-2023
Mitochondrial Regulation of the 26S Proteasome
2020 · Cell Reports · 48 citations
https://doi.org/10.1016/j.celrep.2020.108059
Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis
2023 · iScience · 16 citations
https://doi.org/10.1016/j.isci.2023.108345
Insights into the Cellular and Molecular Mechanisms behind the Antifibrotic Effects of Nerandomilast
2025 · American Journal of Respiratory Cell and Molecular Biology · 15 citations
https://doi.org/10.1165/rcmb.2024-0614oc
Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration
2024 · Journal of Thrombosis and Haemostasis · 5 citations
https://doi.org/10.1016/j.jtha.2024.10.025
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat